---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-023641"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2024-02-14T23:59:59+00:00"
generated_at: "2026-06-06T02:13:55.794386+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Immunome prices $200M follow-on offering of 10M shares at $20/share

## Summary
- Priced 10,000,000 common shares at $20.00 each; gross proceeds ~$200M before expenses.
- Underwriters have 30-day option to purchase up to 1,500,000 additional shares.
- Closing expected February 16, 2024, subject to customary conditions.
- Proceeds intended for general corporate purposes; J.P. Morgan, Cowen, Leerink, Guggenheim lead offering.

## SEC filing metadata
- accession: 0001104659-24-023641
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2024-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/0001104659-24-023641-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000110465924023641/tm246214d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-023641
- JSON: https://secwatch.observer/filing/0001104659-24-023641.json
- Plain text: https://secwatch.observer/filing/0001104659-24-023641.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.